Through a deeper exploration of the underlying mechanisms of lncRNAs and the PI3K/AKT pathway in these tumors, coupled with the development of targeted therapeutic interventions, we can envision substantial advancements in precise diagnosis, prognosis, and treatment methodologies for gastrointestinal tumors. The gene discussed is PIK3CB; the disease is digestive system neoplasm.